Improved hepatic physiology in hepatic cytochrome P450 reductase null (HRN™) mice dosed orally with fenclozic acid

Ítems similars

• Exposure to benzo[a]pyrene of Hepatic Cytochrome P450 Reductase Null (HRN) and P450 Reductase Conditional Null (RCN) mice: Detection of benzo[a]pyrene diol epoxide-DNA adducts by immunohistochemistry and (32)P-postlabelling
  per: Arlt, Volker M., et al.
  Publicat: (2012)
• The Anticancer Drug Ellipticine Activated with Cytochrome P450 Mediates DNA Damage Determining Its Pharmacological Efficiencies: Studies with Rats, Hepatic Cytochrome P450 Reductase Null (HRN™) Mice and Pure Enzymes
  per: Stiborová, Marie, et al.
  Publicat: (2014)
• Relationship between hepatic phenotype and changes in gene expression in cytochrome P450 reductase (POR) null mice
  per: Wang, Xiu Jun, et al.
  Publicat: (2005)
• Application of hepatic cytochrome b(5)/P450 reductase null (HBRN) mice to study the role of cytochrome b(5) in the cytochrome P450-mediated bioactivation of the anticancer drug ellipticine
  per: Reed, Lindsay, et al.
  Publicat: (2019)
• 22 Vasculogenesis defects in cytochrome P450 reductase null mouse embryos
  per: Otto, DME, et al.
  Publicat: (2002)